Atlas Trials

Il-Yang Pharm. Co., Ltd.

33 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Il-Yang Pharm. Co., Ltd.

RecordFirmDate
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers (NCT07433556)Il-Yang Pharm. Co., Ltd.2026-03-23
Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects. (NCT07322991)Il-Yang Pharm. Co., Ltd.2025-10-14
Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T (NCT05617651)Il-Yang Pharm. Co., Ltd.2024-11-30
Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML (NCT06665412)Il-Yang Pharm. Co., Ltd.2024-10-24
Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Infants (NCT04381689)Il-Yang Pharm. Co., Ltd.2024-10-23
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer (NCT06284876)Il-Yang Pharm. Co., Ltd.2024-07-23
Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib (NCT06461078)Il-Yang Pharm. Co., Ltd.2024-07-22
Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC (NCT06471868)Il-Yang Pharm. Co., Ltd.2024-06-10
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac (NCT05558150)Il-Yang Pharm. Co., Ltd.2022-11-10
Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T (NCT05509543)Il-Yang Pharm. Co., Ltd.2022-08-24
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole (NCT05237297)Il-Yang Pharm. Co., Ltd.2022-02-17
Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease (NCT04691661)Il-Yang Pharm. Co., Ltd.2021-09-09
Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China) (NCT03722420)Il-Yang Pharm. Co., Ltd.2018-12-28
Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD (NCT03444883)Il-Yang Pharm. Co., Ltd.2018-10-31
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs (NCT03459534)Il-Yang Pharm. Co., Ltd.2018-06-25
Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents (NCT03445468)Il-Yang Pharm. Co., Ltd.2017-09-20

Track Il-Yang Pharm. Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.